These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8607145

  • 1. A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits.
    Mann S, Droz PO, Vahter M.
    Toxicol Appl Pharmacol; 1996 Mar; 137(1):8-22. PubMed ID: 8607145
    [Abstract] [Full Text] [Related]

  • 2. A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans.
    Mann S, Droz PO, Vahter M.
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):471-86. PubMed ID: 8887465
    [Abstract] [Full Text] [Related]

  • 3. A physiologically based pharmacokinetic model of inorganic arsenic.
    Yu D.
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 1):128-41. PubMed ID: 10341143
    [Abstract] [Full Text] [Related]

  • 4. Arsenic metabolism and thioarsenicals in hamsters and rats.
    Naranmandura H, Suzuki N, Iwata K, Hirano S, Suzuki KT.
    Chem Res Toxicol; 2007 Apr; 20(4):616-24. PubMed ID: 17381137
    [Abstract] [Full Text] [Related]

  • 5. Physiologically based modeling of 2-butoxyethanol disposition in rats following different routes of exposure.
    Shyr LJ, Sabourin PJ, Medinsky MA, Birnbaum LS, Henderson RF.
    Environ Res; 1993 Nov; 63(2):202-18. PubMed ID: 8243415
    [Abstract] [Full Text] [Related]

  • 6. Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences.
    Quick DJ, Shuler ML.
    Biotechnol Prog; 1999 Nov; 15(3):540-55. PubMed ID: 10356275
    [Abstract] [Full Text] [Related]

  • 7. A physiologically based pharmacokinetic (PB/PK) model for multiple exposure routes of soman in multiple species.
    Sweeney RE, Langenberg JP, Maxwell DM.
    Arch Toxicol; 2006 Nov; 80(11):719-31. PubMed ID: 16718492
    [Abstract] [Full Text] [Related]

  • 8. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS.
    Chem Biol Interact; 2007 Mar 20; 166(1-3):352-9. PubMed ID: 17324392
    [Abstract] [Full Text] [Related]

  • 9. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.
    Kenyon EM, Hughes MF, Adair BM, Highfill JH, Crecelius EA, Clewell HJ, Yager JW.
    Toxicol Appl Pharmacol; 2008 Nov 01; 232(3):448-55. PubMed ID: 18706920
    [Abstract] [Full Text] [Related]

  • 10. Comparison of tissue dosimetry in the mouse following chronic exposure to arsenic compounds.
    Gentry PR, Covington TR, Lawrence G, McDonald T, Snow ET, Germolec D, Moser G, Yager JW, Clewell HJ.
    J Toxicol Environ Health A; 2005 Mar 12; 68(5):329-51. PubMed ID: 15799626
    [Abstract] [Full Text] [Related]

  • 11. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats.
    Suzuki KT, Katagiri A, Sakuma Y, Ogra Y, Ohmichi M.
    Toxicol Appl Pharmacol; 2004 Aug 01; 198(3):336-44. PubMed ID: 15276413
    [Abstract] [Full Text] [Related]

  • 12. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
    Fisher JW, Mahle D, Abbas R.
    Toxicol Appl Pharmacol; 1998 Oct 01; 152(2):339-59. PubMed ID: 9853003
    [Abstract] [Full Text] [Related]

  • 13. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.
    Abbas R, Fisher JW.
    Toxicol Appl Pharmacol; 1997 Nov 01; 147(1):15-30. PubMed ID: 9356303
    [Abstract] [Full Text] [Related]

  • 14. Tissue distribution and urinary excretion of dimethylated arsenic and its metabolites in dimethylarsinic acid- or arsenate-treated rats.
    Adair BM, Moore T, Conklin SD, Creed JT, Wolf DC, Thomas DJ.
    Toxicol Appl Pharmacol; 2007 Jul 15; 222(2):235-42. PubMed ID: 17559899
    [Abstract] [Full Text] [Related]

  • 15. Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: tissue accumulation and the reversibility after washout are tissue-selective.
    Lin CJ, Wu MH, Hsueh YM, Sun SS, Cheng AL.
    Cancer Chemother Pharmacol; 2005 Feb 15; 55(2):170-8. PubMed ID: 15322825
    [Abstract] [Full Text] [Related]

  • 16. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
    Greenberg MS, Burton GA, Fisher JW.
    Toxicol Appl Pharmacol; 1999 Feb 01; 154(3):264-78. PubMed ID: 9931286
    [Abstract] [Full Text] [Related]

  • 17. A physiologically based pharmacokinetic description of the oral uptake, tissue dosimetry, and rates of metabolism of bromodichloromethane in the male rat.
    Lilly PD, Andersen ME, Ross TM, Pegram RA.
    Toxicol Appl Pharmacol; 1998 Jun 01; 150(2):205-17. PubMed ID: 9653052
    [Abstract] [Full Text] [Related]

  • 18. Metabolism and excretion of gallium arsenide and arsenic oxides by hamsters following intratracheal instillation.
    Rosner MH, Carter DE.
    Fundam Appl Toxicol; 1987 Nov 01; 9(4):730-7. PubMed ID: 3692028
    [Abstract] [Full Text] [Related]

  • 19. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
    Clewell HJ, Thomas RS, Gentry PR, Crump KS, Kenyon EM, El-Masri HA, Yager JW.
    Toxicol Appl Pharmacol; 2007 Aug 01; 222(3):388-98. PubMed ID: 17499324
    [Abstract] [Full Text] [Related]

  • 20. Metabolism and excretion of orally and intraperitoneally administered gallium arsenide in the hamster.
    Yamauchi H, Takahashi K, Yamamura Y.
    Toxicology; 1986 Sep 01; 40(3):237-46. PubMed ID: 3750324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.